Denna sida på svenska
Loading profile information...

About me

Ola Olén is a pediatric gastroenterologist and senior consultant at the Department of pediatric gastroenterology and nutrition at Sachs’ children and youth hospital. He is also a senior researcher at the Clinical Epidemiology Unit at the Department of Medicine Solna, Karolinska Insitutet.

Education

Education

Specialist in pediatrics, 2011

PhD, 2008, Karolinska Institutet

Medical degree, 2000, Uppsala University.

 

Clinical positions:

2017 – : Senior Consultant, Sachs’ Children’s hospital. Researcher, Karolinska Institutet.

2014 – 2016: Consultant, Sachs’ Children’s hospital. Postdoc, Karolinska Institutet.

2011 – 2013: Specialist in pediatrics, Sachs’ Children’s hospital (0% research)

2002 – 2010: Specialist training, Sachs’ (incl. parental leave and PhD-studies.)

2000 – 2002: Internship, Sunderby Sjukhus

Research description

My research

The aim of my research is to improve healthcare and ultimately quality of life for patients suffering from diseases such as inflammatory bowel disease (IBD) or functional gastrointestinal disorders such as irritable bowel syndrome (IBS).

 

IBD

As a pediatric gastroenterologist, most of my clinical time is devoted to patients with IBD. They are sometimes severely ill and require advanced treatment. My IBD research is conducted in national and international collaboration and is based on clinical data in national health registers and local biobanks. Important research questions that we explore are for instance: Why do some people get IBD? What is the prognosis for different patient groups with IBD (and especially for patients with childhood onset)? Different treatments for IBD – are they safe? And are they cost effective? I am also in the steering committee for the national quality register for IBD care (www.swibreg.se).

 

IBS

Irritable bowel syndrome (IBS) and other types of functional abdominal pain disorders are very common: Approximately 3% of all visits to the general practitioner, 10% of visits to general pediatricians and 25% of visits to a pediatric gastroenterology unit.

 

It is well known that cognitive behavior therapy is effective for children and adolescents with IBS, but access to trained therapists is very limited. In randomized clinical trials we test if it is possible to treat children and adolescents with IBS or functional abdominal pain via internet (read more on www.ontimagen.nu). I am also trying to understand why so many children suffer from IBS by studying risk factors for disease in birth cohorts (BAMSE, n=4000; ALADDIN, n=500) and national health registers. In these data sources we are studying the effects of genetics, perinatal risk factors, lifestyle, co-morbidity, gut flora and use of antibiotics.

 

Selected references:

Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014.
Olén O, Askling J, Sachs M, Frumento P, Neovius M, Smedby K, et al
BMJ 2017 Sep;358():j3951

Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
Everhov , Halfvarson J, Myrelid P, Sachs M, Nordenvall C, Söderling J, et al
Gastroenterology 2017 Nov;():

Surgical treatment in childhood-onset inflammatory bowel disease -A nationwide register-based study of 4,695 incident patients in Sweden 2002-2014.
Nordenvall C, Rosvall O, Bottai M, Everhov Ã, Malmborg P, Smedby K, et al
J Crohns Colitis 2017 Sep;():

Association Between Long-term Oral Contraceptive Use and Risk of Crohn's Disease Complications in a Nationwide Study.
Khalili H, Granath F, Smedby K, Ekbom A, Neovius M, Chan A, et al
Gastroenterology 2016 Jun;150(7):1561-1567.e1

Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study.
Khalili H, Neovius M, Ekbom A, Ludvigsson J, Askling J, Chan A, et al
Am. J. Gastroenterol. 2016 Nov;111(11):1614-1620

Anti-TNF treatment in Crohn's disease and risk of bowel resection-a population based cohort study.
Eberhardson M, Söderling J, Neovius M, Cars T, Myrelid P, Ludvigsson J, et al
Aliment. Pharmacol. Ther. 2017 Sep;46(6):589-598

Internet-Delivered Cognitive Behavior Therapy for Adolescents With Irritable Bowel Syndrome: A Randomized Controlled Trial.
Bonnert M, Olén O, Lalouni M, Benninga M, Bottai M, Engelbrektsson J, et al
Am. J. Gastroenterol. 2017 Jan;112(1):152-162

Internet-Delivered Cognitive Behavioral Therapy for Children With Pain-Related Functional Gastrointestinal Disorders: Feasibility Study.
Lalouni M, Ljótsson B, Bonnert M, Hedman-Lagerlöf E, Högström J, Serlachius E, et al
JMIR Ment Health 2017 Aug;4(3):e32

Exposure-Based Cognitive Behavior Therapy for Children with Abdominal Pain: A Pilot Trial.
Lalouni M, Olén O, Bonnert M, Hedman E, Serlachius E, Ljótsson B
PLoS ONE 2016 ;11(10):e0164647

Teaching portfolio

Dr Olén served as the director of studies 2009-2013 for the widely acclaimed Research school in epidemiology for clinicians at the Karolinska Instituet. He is director of a national course in pediatric gastroenterology, hepatology and nutrition, funded by the National Board of Health and Welfare since 2013. Dr Olén is a valued teacher and often engaged as a lecturer regarding inflammatory bowel disease, irritable bowel syndrome, and epidemiology.

Academic honours, awards and prizes

- Clinical researcher award 2017 ("klinisk forskartjänst"), Karolinska Institutet.

- Mag- Tarmfondens stora pris 2016 (”the great prize of the Swedish gastro society”).

- Bengt Ihre research fellowship in gastroenterology 2014-2016 (www.ihrefellowship.se). Awarded by the Swedish medical association to promising future research leaders in gastroenterology. Includes a 2 year grant and networking activities with prominent researchers in gastroenterology during the grant period and afterwards.

- ìShizu Matsumuraîs donation 2013, to prominent pediatric research at KI.

Loading publication list...